The A118G single nucleotide polymorphism (SNP) of the human µ fopioid receptor (MOPR) gene (OPRM1) was associated with heightened dopamine release by alcohol intake, better treatment outcome for nicotine and alcohol addiction and reduced analgesic responses to morphine. A mouse model that possesses the equivalent substitution (A112G) in the oprm1 gene was generated to delineate the mechanisms of the impact of the SNP. Mice homozygous for the G allele (G/G) displayed lower morphine-induced antinociception than A/A mice, similar to humans. In this study, we examined whether A112G SNP affected MOPR-mediated G protein activation in the mouse model. We compared A/A and G/G mice in the MOPR selective agonist DAMGOstimulated [ 35 S]GTPγS binding in brain regions by autoradiography. When the data of males and females were combined, G/G mice exhibited lower DAMGO-stimulated [ 35 S]GTPγS binding in the VTA than A/A mice, in accord with previously reported reduced morphine-induced hyperactivity and locomotor sensitization in G/G mice. In the NAc core, female G/G mice displayed lower DAMGO-stimulated [ 35 S]GTPγS binding than female A/A mice, which is consistent with previously reported deficiency in morphine-induced conditioned place preference in female G/G mice. In G/G mice, males showed higher DAMGO-stimulated [ 35 S]GTPγS binding than females in the cingulate cortex, CPu, NAc core, thalamus and amygdala. Thus A112G SNP affects DAMGO-stimulated [ 35 S]GTPγS binding in region-and sex-specific manners.
Introduction
The A118G single nucleotide polymorphism (SNP) of the human µ opioid receptor gene (OPRM1) is the most common SNP in the coding region of the MOPR (Bergen, Kokoszka, Peterson et al., 1997; Bond, LaForge, Tian et al., 1998) . This SNP results in a change of amino acid at position 40 from asparagine to aspartate (N40D) in the N-terminal domain, which removes one of five potential N-linked glycosylation sites of the receptor (Bergen et al., 1997; Bond et al., 1998) . Recently we reported that this SNP reduced the Nglycosylation and stability of the MOPR protein (Huang, Chen, Mague et al., 2012) . The A118G allele frequency varies among ethnic groups: 1-3% in African Americans, 10-14% in both Caucasians and Hispanics, 35-49% in Asians and 8-21% in other populations [reviewed in (Kreek, Bart, Lilly et al., 2005; Mague and Blendy, 2010) ]. Clinical studies revealed that among alcohol dependent patients treated with naltrexone, those with one or two copies of the G118 allele had better outcome (Oslin, Berrettini, Kranzler et al., 2003; Kim, Kim, Choi et al., 2009) . Among individuals using transdermal nicotine for smoke cessation, those of the A/G and G/G genotype had better responses (Lerman, Wileyto, Patterson et al., 2004) . Ramchandani, Umhau, Pavon et al. (2011) reported that alcohol intake induced dopamine release in carriers of the G118 allele, but not in A118 homozygotes. In addition, subjects with G118 allele needed higher morphine doses to attain adequate pain control for acute postoperative pain compared to those homozygous for the A118 allele subjects (Chou, Wang, Liu et al., 2006; Chou, Yang, Lu et al., 2006; Sia, Lim, Lim et al., 2008; Hayashida, Nagashima, Satoh et al., 2008; Campa, Gioia, Tomei et al., 2008) . Studies on the role of G118 allele in alcohol or drug dependence have reported positive, negative, or no associations [for reviews, see (Kreek et al., 2005; Mague and Blendy, 2010) ]. Mague, Isiegas, Huang et al. (2009) generated a mutant mouse line that possessed the mouse equivalent (A112G, N38D) of the human SNP for studying the mechanisms underlying the changes associated with OPRM1 A118G SNP in humans. The mice homozygous for G112 allele (G/G mice) displayed reduced antinociceptive responses to morphine than those homologous for A112 allele (A/A mice) (Mague et al., 2009) , similar to the results in humans. In addition, G/G mice showed reduced morphine-induced hyperactivity and locomotor sensitization (Mague et al., 2009) . Moreover, female, not male, G/G mice failed to show a conditioned place preference to morphine-paired environments (Mague et al., 2009) . Recently, Ramchandani et al. (2011) have also generated a mouse model of the OPRM1 A118G SNP by replacing the mouse exon 1 with the human exon 1 carrying the A118 or G118 allele. They found that homozygous G118 mice showed a 4-fold greater peak dopamine response to an alcohol challenge as homozygous A118 mice. Furthermore, Mahmoud, Thorsell, Sommer et al. (2011) reported that the potency and efficacy of morphine in modulating Ca 2+ channels were reduced in sensory neurons of mice expressing the 118 GG gene compared with those expressing the 118AA version.
We have demonstrated that mice with oprm1 A112G displayed lower MOPR expression in some, but not all, brain regions (Wang, Huang, Ung et al., 2012) . The effects of A112G on MOPR protein expression have sex differences in some brain regions (Wang et al., 2012) . In the mouse brains A112G reduced N-glycosylation of the MOPR and in cultured cells A118G in the human MOPR decreased N-glycosylation and protein stability . The reduction in MOPR expression in brain regions by the A112G (Wang et al., 2012 ) is likely to be involved in attenuated morphine-induced antinociception, hyperactivity and locomotor sensitization (Mague et al., 2009 
Materials and methods

Animals
A112G-MOPR knock-in mice were generated on C57BL/6 genetic background in Dr. Blendy's laboratory. The animals (8-15 weeks, 18-30 g) were housed in the University of Pennsylvania animal facility and maintained on a 12 h light/dark cycle with ad libitum access to food and water. Animals were used in accordance with the methods approved by University of Pennsylvania Animal Care and Use Committee. Mice homozygous for the A112 or G112 allele are used for the study. 
In vitro autoradiography of DAMGO-stimulated [ 35 S]GTPγS binding
The experiments were conducted according to our published procedures, which were adapted from those of Sim-Selley, Selley, Vogt et al., 2000) . Coronal sections (20 µm) of regions of interest were cut on a cryostat (Leica CM3050 S) maintained at −20°C, thaw-mounted onto gelatin-subbed slides, and stored at −80°C until processed. Sections were incubated with 2 mM GDP in [ 35 S]GTPγS binding buffer (50 mM Tris-HCl, 3 mM MgCl 2 , 0.2 mM EGTA, 100 mM NaCl, pH 7.4) for 15 min at 25°C, and then incubated for 2 hr at 25°C in [ 35 S]GTPγS binding buffer with 0.04 nM [ 35 S]GTPγS and 2 mM GDP with or without the µ agonist DAMGO (10 µM). After incubation, sections were rinsed twice (2 minutes each) in cold 50 mM Tris-HCl buffer, pH 7.4, once (30 seconds) in deionized H 2 O, and then dried thoroughly and exposed to phosphor screens for 48 hr in cassettes along with [ 14 C]microscales for densitometric analysis.
Autoradiography data analysis-Images captured on phosphor screens were visualized using a Cyclone Storage Phosphor Scanner (Packard Bioscience) and data were analyzed using the OptiQuant program associated with scanner. Images were quantified by densitometric analysis with [ 14 C] standards. A brain paste standard assay was performed to determine the correction factor necessary to calculate nCi/g for [ 35 S] from nCi/g for [ 14 C], as previously described . Net agonist-stimulated [ 35 S]GTPγS binding was calculated by subtracting basal binding (obtained in the absence of agonist) from agonist-stimulated binding. Data were reported as mean values ± S.E.M.
Statistical analysis
Two-way ANOVA was used to determine statistical significant differences between groups, with sex and genetic factor as main factors. For comparison of two groups within one factor, two-tailed Student's t test was performed. *p<0.05, **p<0.01 was the level of significance in all statistical analyses.
Results
DAMGO-stimulated [ 35 S]GTPγS binding in A/A and G/G mouse brains
DAMGO-stimulated [ 35 S]GTPγS binding, a measure of MOPR-mediated G protein activation (Traynor and Nahorski, 1995; Sim, Selley, and Childers, 1995) , was performed on coronal sections of both the A/A and G/G mouse brains at 3 anatomical levels. There is no difference between A/A and G/G on the overall anatomical distribution of G protein activation; therefore, representative autoradiograms of DAMGO-stimulated [ 35 S]GTPγS binding in male A/A mice are shown in Fig. 1 . High levels of DAMGO-stimulated [ 35 S]GTPγS binding were observed in the cortices, CPu, NAc in the telencephalon (Fig.  1A ) and in the thalamus, hypothalamus and amygdala in the diencephalon (Fig. 1B) . In the midbrain, DAMGO-stimulated [ 35 S]GTPγS binding were found in the substantial nigra, PAG and VTA, albeit at lower levels (Fig. 1C) .
We compared the levels and distribution of the DAMGO-stimulated 
Sex Differences in net DAMGO-stimulated [ 35 S]GTPγS binding
To explore if there are sex differences in basal or DAMGO-stimulated [ 35 S]GTPγS binding in A/A and G/G mice, the data of males and females were analyzed separately. There were no sex differences in basal [ 35 S]GTPγS binding in A/A or G/G mice in any of the brain regions. As shown in Fig. 3 , males G/G mice showed significantly higher net DAMGO-stimulated [ 35 S]GTPγS binding than female G/G mice in the cingulate cortex, CPu, NAc core, thalamus and amygdala. In contrast, there are no sex differences in A/A mice. In addition, in the NAc core, female A/A mice displayed significantly higher DAMGOstimulated [ 35 S]GTPγS binding than female G/G mice (Fig. 4) .
Discussion
The current studies demonstrated that A112G SNP led to lower DAMGO-stimulated [ 35 S]GTPγS binding in the VTA. In addition, A112G SNP resulted in reductions in DAMGO-stimulated [ 35 S]GTPγS in the NAc core in females, but not in males. These biochemical changes resulting from A112G SNP may correlate with alterations in morphineinduced in vivo pharmacological effects, which are discussed below.
Our results are different from those of (Ramchandani et al., 2011) on the A118G mice they generated. They found that there were no differences between G/G and A/A mice in DAMGO-stimulated [ 35 S]GTPγS binding in the dorsal striatum, NAc and VTA. The discrepancy may be due to different mouse models used. The mice used in the present study has A112G substitution in the mouse MOPR sequence, where those in the Ramchandani et al. (2011) study have the first exon of the human MOPR gene with A118 and G118 in A/A and G/G mice, respectively.
Reduced DAMGO-stimulated [ 35 S]GTPγS binding by A112G SNP in the VTA may be related to decreased morphine-induced hyperactivity and locomotor sensitization
VTA plays an important role in morphine-induced hyperactivity and locomotor sensitization (Bunney, Massari, and Pert, 1984; Kalivas and Duffy, 1987) . Our observations that A112G SNP led to reduced DAMGO-stimulated [ 35 S]GTPγS binding in VTA are consistent with the findings that G/G mice showed decreased morphine-induced hyperactivity and locomotor sensitization (Mague et al., 2009 ). In addition, we have demonstrated that A112G SNP results in reduced MOPR expression in the VTA (Wang et al., 2012) , which may play a role as well.
Reduced DAMGO-stimulated [ 35 S]GTPγS binding in the NAc core of female G/G mice may contribute to impaired morphine-induced conditioned place preference
The NAc is a key neural substrate involved in rewarding properties of drugs of abuse, including morphine (Koob, Sanna, and Bloom, 1998) . We found that in the NAc core female G/G mice displayed significantly lower DAMGO-stimulated [ 35 S]GTPγS binding than female A/A mice; however, there is no difference between male A/A and male G/G mice. These differences are likely to contribute to the previous report that female G/G mice failed to show a morphine-induced conditioned place preference, in contrast to female A/A, male A/A and male G/G mice (Mague et al., 2009 ).
Effects of A112G SNP on DAMGO-stimulated [ 35 S]GTPγS binding have sex differences
We found that among G/G mice males displayed higher DAMGO-stimulated [ 35 S]GTPγS binding than females in the cingulate cortex, CPu, thalamus, NAc core and amygdala; however, no sex differences were observed among A/A mice. These results indicate that the sex differences are limited to the G/G mice in these regions. In future studies, it may be important to examine if sex differences are present in the G/G mice in behavioral endpoints mediated by the MOPR in these brain regions.
We have found that male A/A mice showed higher [ 3 H]DAMGO binding than G/G mice in more brain regions than female A/A over G/G (Wang et al., 2012 (Wang et al., 2012) . N-linked glycosylation (Knezevic, Polasek, Gornik et al., 2009; Stanta, Saldova, Struwe et al., 2010; Huang et al., 2012) , regional differences in MOPR-G protein coupling efficiency (Wang, Rasakham, Huang et al., 2011) , hormonal state (Loyd, Wang, and Murphy, 2008) , and epigenetic regulation [reviewed in (Jessen and Auger, 2011) ] may influence sex-specific protein expression. It appears that these factors affect G/G mice, but not A/A mice, of which the underlying mechanisms remain to be investigated.
Lack of correlation between DAMGO-stimulated [ 35 S]GTPγS binding and receptor levels
We found that A112G SNP led to reduced DAMGO-stimulated [ 35 S]GTPγS binding only in the VTA when data of male and female mice were combined. In contrast, our previous studies revealed that A112G SNP resulted in lower MOPR expression in several brain regions, including VTA, cortices, NAc, hypothalamus, amygdala, PAG, and superficial layers of the superior colliculus (Wang et al., 2012) . Our data indicate that changes in DAMGO-stimulated [ 35 S]GTPγS binding levels do not correlate with alterations in MOPR levels. A similar lack of a close correlation has been observed between mu, kappa or cannabinoid receptor and G protein activation (Breivogel, Sim, and Childers, 1997; Vogt, Sim-Selley, Childers et al., 2001; Wang et al., 2011) . The mechanisms underlying these discrepancies are not yet clear, but some factors may be involved. The ratios of receptor to G proteins may vary among brain regions. MOPRs have been shown to activate different types of G proteins (Chakrabarti, Prather, Yu et al., 1995) , which may lead to different numbers of G proteins activated per receptor in different regions. It is also possible that some MOPRs may not be coupled functionally, due to their intracellular location (Wang, Van Bockstaele, and Liu-Chen, 2008 ).
Regional differences in basal [ 35 S]GTPγS binding
In the VTA, G/G mice (males and females pooled) exhibited significantly higher basal [ 35 S]GTPγS binding than A/A mice. In most of the other regions, G/G mice showed a trend of higher basal levels, but they did not reach statistical significance. Previously Mague et al. (2009) reported lower MOPR protein levels by immunoblotting and lower B max value of [ 3 H]DAMGO binding to the MOPR in the brains of G/G mice, compared to A/A mice. We also found that A/A mice displayed higher MOPR expression than G/G mice in both males and females (Wang et al., 2012) . Therefore, the higher basal [ 35 S]GTPγS binding in G/G mice is not due to differences in the MOPR level. Basal [ 35 S]GTPγS binding may represent constitutive (agonist-independent) activation of Gα subunits of trimeric G proteins and many other guanine nucleotide binding proteins present in the brain. Differences in levels and activities of these guanine nucleotide binding proteins may contribute to the differences in basal [ 35 S]GTPγS binding between A/A and G/G mice. It has also been shown that [ 35 S]GTPγS binding to NDPK accounts for part of the high basal binding (Zhang, Li, Chen et al., 1999 Sim, Selley, Dworkin et al. (1996) . GDP is required to reduce basal [ 35 S]GTPγS binding (Traynor and Nahorski, 1995) and the concentration required varies among cells and tissues (Huang, Xu, Yoon et al., 2007) . It is conceivable that brain regions may require different GDP concentrations to achieve similar basal [ 35 S]GTPγS binding. However, we had to use one concentration of GDP (2 mM) in the experiment for all brain regions, which may contribute to varying levels of basal [ 35 S]GTPγS binding. Thus, the net DAMGO-stimulated [ 35 S]GTPγS binding as % of basal binding is consequently variable across brain regions and is quite low in some regions, which are consistent with the finding of (Wang et al., 2011) and Sim et al. (1996) .
In summary, A112G affected DAMGO-stimulated [ 35 S]GTPγS binding in region-and sexspecific manners. A112G SNP led to reduced DAMGO-stimulated [ 35 S]GTPγS binding in the VTA, which may be associated with lower morphine-induced hyperactivity and locomotor sensitization. There are sex differences in the effects of A112G SNP in NAc core that may contribute to lack of morphine-induced conditioned place preference in female G/G mice. In G/G mice males showed significantly higher net DAMGO-stimulated [ 35 S]GTPγS binding than females in some brain areas, of which the in vivo pharmacological consequences remain to be examined. Sections were incubated with ~0.04 nM [ 35 S]GTPγS and 2 mM GDP in the absence (basal) or presence of 10 µM DAMGO for 2 hr at 25°C, washed, dried, and exposed to phosphor screens for 48 hr. Abbreviation: cc, cingulate cortex; mc, motor cortex; sc, somatosensory cortex; ic, insular cortex; cpu, caudate putamen; acb, nucleus accumbens; hpc, hippocampus; hyp, hypothalamus; thl, thalamus; amg, amygdala; pag, periaqueductal gray; sn, substantial nigra; sug, superficial grey of superior colliculus; vta, ventral tegmental area. Experiments were carried out as described in Fig. 1 legend. Data are expressed at mean ± S.E.M. of five to six animals, three or four sections from each brain. *p < 0.05, **p < 0.01 different from A/A female by the non-paired two-tailed Student's t test.
